Regarding leflunomide in pregnancy all are true except
**Question:** Regarding leflunomide in pregnancy all are true except
A. LEFفلونوميد is an immunosuppressive drug used in the treatment of rheumatoid arthritis (RA) and psoriasis.
B. LEFflunomide crosses the placenta and can lead to fetal toxicity.
C. LEFflunomide is safe for use during pregnancy without any adverse effects.
D. LEFflunomide is a potent inducer of CYP3A4 enzyme in the liver, which can affect other medications.
**Correct Answer: C. LEFflunomide is safe for use during pregnancy without any adverse effects.**
**Core Concept:** Leflunomide (LEF) is an immunosuppressive drug primarily used in the treatment of rheumatoid arthritis (RA) and psoriasis. Leflunomide belongs to the class of drugs known as pyrimidine synthesis inhibitors, which means it interferes with the production of nucleic acids and thus suppresses the immune system.
**Why the Correct Answer is Right:** Leflunomide does cross the placental barrier, which means that fetal exposure to leflunomide is possible during pregnancy. The primary concern with leflunomide during pregnancy is fetal toxicity, as it can cause congenital abnormalities and preterm birth. The drug can lead to teratogenic effects, including limb abnormalities, cardiovascular anomalies, and craniofacial defects.
**Why Each Wrong Option is Incorrect:**
**A. LEFflunomide is an immunosuppressive drug used in the treatment of rheumatoid arthritis (RA) and psoriasis:** This statement is true, but it does not address the safety of leflunomide during pregnancy.
**B. LEFflunomide crosses the placenta and can lead to fetal toxicity:** This statement is correct, as mentioned earlier, fetal exposure to leflunomide is possible, and it can cause congenital abnormalities and preterm birth.
**D. LEFflunomide is a potent inducer of CYP3A4 enzyme in the liver:** This statement is true, as leflunomide is a substrate for CYP3A4, an enzyme involved in drug detoxification. However, this does not negate the teratogenic risk during pregnancy.
**C. LEFflunomide is safe for use during pregnancy without any adverse effects:** This statement is incorrect. Leflunomide is associated with fetal toxicity, as explained above.
**Core Concept:** Leflunomide is a potent inhibitor of pyrimidine synthesis, which leads to immunosuppression, making it useful in the treatment of RA and psoriasis. However, its use during pregnancy carries significant risks.
**Why Each Wrong Option is Incorrect:**
**A. LEFflunomide is an immunosuppressive drug used in the treatment of rheumatoid arthritis (RA) and psoriasis:** This statement is true, but it does not address the safety concerns during pregnancy.
**B. LEFflunomide crosses the placenta and can lead to fetal toxicity:** This statement is